Quarterly report pursuant to Section 13 or 15(d)

GENERAL (Details Narrative)

v3.22.2.2
GENERAL (Details Narrative) - USD ($)
9 Months Ended
Apr. 05, 2022
Mar. 17, 2022
Mar. 11, 2022
Jan. 13, 2022
Sep. 30, 2022
Sep. 30, 2021
Nov. 14, 2022
Jun. 30, 2022
Mar. 31, 2022
Mar. 14, 2022
Dec. 31, 2021
Jun. 30, 2021
Apr. 19, 2021
Mar. 31, 2021
Dec. 31, 2020
Jul. 28, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
Investment         $ 1,733                      
New issues shares       1,250,000                        
Accumulated losses         110,596,000           $ 90,595,000          
Working capital         11,624,000                      
Stockholders' equity         30,635,000 $ 10,499,000   $ 29,796,000 $ 24,421,000   24,212,000 $ 8,999,000   $ 19,458,000 $ 11,011,000  
Cash and cash equivalent         57,000           189,000          
Revenues recognized         6,276,000 7,773,000                    
Subsequent Event [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
Cash and cash equivalent             $ 215,000                  
Common Stock [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
New issues shares   16,000,000                            
Stockholders' equity         $ (4,045,000) $ (2,593,000)   $ (3,557,000) $ (3,423,000)   $ (2,913,000) $ (1,765,000)   $ (1,595,000) $ (1,059,000)  
Breakthrough Diagnostics Inc [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
Percentage of issued and outstanding common stock                               100.00%
Molecular Diagnostics [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
Percentage of issued and outstanding common stock                         100.00%      
GB Plus Ltd [Member] | Common Stock [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
New issues value $ 396,000                              
New issues shares 24,000,000                              
GB Plus Ltd [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
Equity method investment, ownership percentage 51.00%                              
Share purchase agreement [Member] | 3CL Science Ltd [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
New issues value     $ 8,000,000                          
Share purchase agreement [Member] | 3CL Science Ltd [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
Equity method investment, ownership percentage     52.00%                          
Share purchase agreement [Member] | NLC Pharma Ltd [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
Equity method investment, ownership percentage     48.00%                          
Securities Purchase Agreement [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
New issues value     $ 3,800,000                          
Securities Purchase Agreement [Member] | NLC Pharma Ltd [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
New issues value     $ 2,000,000                          
Line Of Credit Agreement [Member] | Provista Diagnostics Inc [Member]                                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                                
Equity method investment, ownership percentage                   10.00%